A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Search:
Medline
CancerConsultants.com
Both
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here
Conference C overage
Chemotherapy Foundation Symposium 2005
Date: November 2-5, 2005
Location: New York, New York
Author: Jennifer Maxon, RN, and Charles H. Weaver, MD

Next-Generation Chemotherapy - Abraxane Active in Malignant Melanoma, Lung, Head and Neck, and Breast Cancers
By Jennifer Maxon, RN, and Charles H. Weaver, MD

Related News Stories
Nipent®/Cytoxan®/Rituxan® Shows High Activity in High-Risk Chronic Lymphocytic Leukemia (11/23/2005)

Sunitinib Malate (SU11248) Promising for Metastatic Renal Cell Carcinoma (11/17/2005)

Addition of Genasense® to Dacarbazine Improves Outcomes in Metastatic Melanoma Patients with Normal LDH (11/16/2005)

Reduced-Intensity Allogeneic Stem Cell Transplants with Pentostatin and Extracorporeal Photopheresis Promising for Some Patients (11/16/2005)

Addition of Iressa® To Tarceva/Avastin Does Not Improve Outcomes in Renal Cell Carcinoma (11/15/2005)

Updated Results of Tarceva™/Avastin® in Renal Cell Carcinoma (RCC) (11/15/2005)

Oral Hycamtin® Better than Best Supportive Care for Recurrent Small Cell Lung Cancer (11/14/2005)

Zometa® Reduces and Recovers Bone Loss from Androgen Deprivation Therapy in Prostate Cancer (11/14/2005)

Hyperthermia May Improve Response to Doxil® in Metastatic Breast Cancer of the Chest Wall (11/11/2005)

Aminopyrimidine Inhibitor, AMN107, Effective for Gleevec®-Resistant Chronic Myeloid Leukemia (11/11/2005)

Abraxane™ Effective for Initial Treatment of Metastatic Non-Small Cell Lung Cancer (11/11/2005)

Phase II Trial of Panitumumab Plus FOLFIRI for Metastatic Colorectal Cancer (11/11/2005)

Prophylactic G-CSFs May Reduce Infection-Related Mortality (11/11/2005)

Premenopausal Women Have Improved Survival with Xyotax® for Treatment of Non-Small Cell Lung Cancer (11/11/2005)

Abraxane™ Shows Significant Activity for the Treatment of Metastatic Melanoma (11/11/2005)

Intraperitoneal Hycamtin® Consolidation Therapy Promising for Advanced Ovarian Cancer (11/10/2005)

Thalidomide Improves Progression-Free Survival, Not Overall Survival in Recurrent Ovarian Cancer (11/7/2005)

Weekly Administration of Topotecan Effective for Recurrent Ovarian Cancer (11/7/2005)

Tumor Protein Highly Predictive to Response to Abraxane™ in Head and Neck Cancer (11/7/2005)

Addition of Taxotere® to Standard Chemotherapy Improves Survival in Advanced Gastric Cancer (11/4/2005)

Newsletters
Register in our member center today to receive a monthly newsletter with conference coverage updates.
Learn More »
Practice Resources
Learn how to have our conference coverage on your website.
Learn More »
Coming Soon
More Conference Coverage
2007 Coverage
2006 Coverage
2005 Coverage
2004 Coverage
2003 Coverage
2002 Coverage
2001 Coverage
Additional Resources
Information by Cancer Type



© 1998-2007 CancerConsultants.com  All Rights Reserved.